Morgan Stanley analyst Nigel Dally maintains American Equity Inv (NYSE:AEL) with a Equal-Weight and lowers the price target from $41 to $40.
Trevena Announces Approval Of OLINVYK In China; Approval Achieves $3M Milestone To Trevena From Jiangsu Nhwa
Trevena's partner, Jiangsu Nhwa, receives approval from Chinese National Medical Products Administration (NMPA)
Approval achieves $3 million milestone to Trevena from Jiangsu Nhwa
Additional $15 million to Trevena expected on first commercial sale in China, based on ex-US Royalty-Based Financing with R-Bridge Healthcare Fund, an affiliate of CBC Group
